The current status of Vinorelbine (Navelbine) in advanced non-small cell lung cancer. SymposiumSeminars in oncology. 1994, Vol 21, Num 5, issn 0093-7754, 91 p., SUP10Conference Proceedings

Measuring quality of life : an emerging science. DiscussionMOINPOUR, C. M; GRALLA, M; COLTMAN, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 48-63, issn 0093-7754, SUP10Conference Paper

The clinical pharmacokinetics of Vinorelbine (Navelbine)WARGIN, W. A; LUCAS, V. S.Seminars in oncology. 1994, Vol 21, Num 5, pp 21-27, issn 0093-7754, SUP10Conference Paper

Vinorelbine (Navelbine) in non-small cell lung cancer : future directionsCRAWFORD, J.Seminars in oncology. 1994, Vol 21, Num 5, pp 85-88, issn 0093-7754, SUP10Conference Paper

Current management of unresectable non-small cell lung cancer. DiscussionLIVINGSTON, R. B; GRALLA, M; COLTMAN, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 4-13, issn 0093-7754, SUP10Conference Paper

Summary of data from in vitro and phase I Vinorelbine (Navelbine) studies. DiscussionBURRIS, H. A; FIELDS, S; GRALLA, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 14-20, issn 0093-7754, SUP10Conference Paper

Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancerVIALLET, J; AYOUB, J; ROUSSEAU, P et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 64-72, issn 0093-7754, SUP10Conference Paper

A summary of vinorelbine (Navelbine) safety data from North American clinical trials. DiscussionHOHNEKER, J. A; CRAWFORD, M; O'ROURKE, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 42-47, issn 0093-7754, SUP10Conference Paper

Vinorelbine (Navelbine)/carboplatin combination therapy : dose intensification with granulocyte colony-stimulating factor. DiscussionCRAWFORD, J; O'ROURKE, M. A; COLTMAN, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 73-78, issn 0093-7754, SUP10Conference Paper

Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer : a preliminary report. DiscussionVOKES, E. E; ROSENBERG, R; HOHNEKER, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 35-41, issn 0093-7754, SUP10Conference Paper

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer : rationale and study design. DiscussionVOKES, E. E; DRINKARD, L. C; GRALLA, M et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 79-84, issn 0093-7754, SUP10Conference Paper

A three-arm trial of Vinorelbine (Navelbine) plus cisplatin vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer : an expanded analysis. DiscussionLE CHEVALIER, T; PUJOL, J.-L; BERTHAUD, P et al.Seminars in oncology. 1994, Vol 21, Num 5, pp 28-34, issn 0093-7754, SUP10Conference Paper